PMS And Menstrual Health Supplements Market Size, Share, Growth, Trends | Report 2023-2032
The global PMS and menstrual health supplements market was valued at USD 22.65 billion in 2022 and it is predicted to surpass around USD 39.32 billion by 2032 with a CAGR of 5.67% from 2023 to 2032.
Report Highlights
One of the major factors contributing to the growth of the market is increased awareness among women about the health hazards related to menstrual health. Traditional diets these days are not able to meet daily nutrient requirements, hence, many physicians are recommending women add health supplements to their daily routine, thus increasing the market growth. The emergence of the COVID-19 pandemic led to increasing awareness about physical and mental health. Additionally, trending e-commerce has eased access to health supplements. Furthermore, industry players globally are focusing on the R&D of new nutritional products to meet market demand.
A study published in the General Psychiatry Journal suggests that 90% of women will experience mild to severe premenstrual syndrome in 2020. To help patients handle premenstrual syndrome, leading manufacturers in the field of PMS treatments are focusing on the consumption of vitamin and nutritional supplements. Years of studies show several vitamins and minerals, including vitamin B, vitamin C, magnesium, and calcium, are vital nutrients in treating PMS-related symptoms. Among all these nutrients, Vitamin B is the most essential and helps to lower PMS.
In 2022, Asia Pacific held a dominant revenue share. Demand for these supplements in the Asia Pacific region will be fuelled by the increasing number of PMS cases, thus giving rise to the general wellness trend. China held the largest share in the Asia Pacific market in 2022, followed by India and Japan. The Middle East and Africa is estimated to witness the fastest growth during the forecast period. Iran shows a high rate of PMS prevalence in the MEA. Numerous lucrative business opportunities are expected to arise as a result of the rising popularity of healthy lifestyles.
| Report Coverage | Details |
| Market Size in 2022 | USD 22.65 billion |
| Revenue Forecast by 2032 | USD 39.32 billion |
| Growth rate from 2023 to 2032 | CAGR of 5.67% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segmentation | Product, consumer group, formulation, sales channel, region |
| Companies Covered | Herbalife International of America, Inc.; Pharmavite LLC; Nature’s Bounty; Amway; GNC Holdings, Inc.; USANA Health Sciences, Inc.; GlaxoSmithKline Plc; MetP Pharma AG; RBK Nutraceuticals Pty Ltd.; Archer Daniels Midland; Power Gummies; Looni; DM Pharma |
Product Insights
Combined nutritional supplements captured a dominant revenue share of over 50.04% in 2022. Certain vitamins and minerals must be taken together to relieve PMS symptoms. Effective combinations include magnesium and vitamin D3, omega 3 and vitamin E, and magnesium and zinc. To prevent undesirable consequences, patients should always consult the doctor for better safety. Combination medications eliminate the need for patients to remember to take multiple supplements on a daily basis. Furthermore, years of research show that combination supplements are effective in terms of therapeutic response, and they can be easily used with proper consultation.
Single nutritional supplements are expected to grow significantly over the forecast period. They offer reliability, which makes them better options to recommend by physicians too. To ensure good nutrition, physicians are highly recommending the consumption of supplements in the diet. Vitamins are the most essential nutrients that show positive effects on the physical and psychological symptoms of PMS. As per the NCBI report, high dose of Vitamin D supplementation can reduce the prevalence of PMS. In the U.S., the use of nutritional supplements is pervasive and undeniably on the growth. The expansion of the supplement market is most likely fueled by the widespread availability and aggressive marketing by industry leaders.
Consumer Group Insights
The PMS segment held the largest share of over 55.13% in 2022 and will continue to grow in the coming years. Factors contributing to this growth are the effectiveness of nutritional supplements on premenstrual syndrome. Studies show calcium and vitamin B6 offer better results in PMS treatment. Additionally, there are some herbal supplements in the market that are used to cope with PMS symptoms. Some herbal supplements such as black cohosh, chaste berry, and evening primrose oil are commonly used. Supplements that can work effectively such as phytoestrogens, calcium, dehydroepiandrosterone, vitamins, bioidentical hormone, and omega-3s are trending in demand.
Perimenopause symptoms can be controlled with the intake of lots of vegetables and fruits, however, it may be necessary to take supplements to cope with the conditions. As a result, the use of supplements in the treatment of perimenopause symptoms is gaining popularity. Perimenopause supplements are typically a blend of botanicals, vitamins, and minerals that are used to alleviate one or more symptoms that women experience during perimenopause.
Formulation Insights
The tablet/capsules segment held the largest revenue share of over 45.03% in 2022. One of the major factors that contribute to the growth of this segment is the ease of use and increased awareness. As per the NCIB report, the most common formulation for oral administration is capsule. Tablets/capsules offer longer shelf life, act quickly and effectively, and can be sugar coated, making them more palatable.
Softgels are gaining huge popularity, which makes them the second-best choice for patients. Softgels are made of gelatins, which are easy to digest and dissolve within minutes of reaching the stomach. DM Pharma, an Indian pharmaceutical company, is promoting the quality of life for women suffering from PMS by providing black cohosh soft gelatin capsules that contain substances similar to female hormones. Nowadays, vitamin injections are gaining popularity, however, the USFDA consider injections to be drugs and not supplements, which hinders their growth in the supplement market.
Sales Channel Insights
Pharmacies/drug stores held the largest revenue share of over 30.07% in 2022. Pharmacies or drug stores generate more sales because they are readily available, and one can buy supplements in a very simple manner within various pharmacy layouts. Furthermore, with the help of pharmacy stores, patients no longer have to wait 3-4 business days for medicines, making this channel more feasible and reliable.
The online segment is expected to grow significantly in the upcoming years. Easy access to the internet plays a crucial role in expanding the online market. The COVID-19 pandemic has developed online purchasing habits and thus, e-commerce platforms are going to increase more significantly. According to an industry report, a survey conducted in India in March 2022 found that nearly 51% of respondents who use nutraceuticals or dietary supplements purchased them online.
Regional Insights
Asia Pacific captured the largest revenue share of over 35.12% in 2022. China captured the largest revenue share in 2022, followed by India and Japan. An increase in the demand for supplements and other natural supplements is fueling growth. Asia Pacific is known for traditional medicines or supplements. Dong quai is a popular PMS supplement in the Asia Pacific region, particularly in China. Inochinohaha White, a Japanese herbal supplement, is widely used to treat anxiety associated with premenstrual syndrome in women.
The MEA is estimated to witness the fastest growth during the forecast period. As per the article published by BMC women’s health in 2021, Iran has the highest prevalence of PMS, and thus, it plays a crucial role in increasing the demand for supplements. High stress in adolescents due to physiological changes, educational pressure, and sexual health are additional reasons behind the rising prevalence, which encourages more frequent use of PMS supplements, thus boosting overall industry growth.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on PMS And Menstrual Health Supplements Market
5.1. COVID-19 Landscape: PMS And Menstrual Health Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global PMS And Menstrual Health Supplements Market, By Product
8.1. PMS And Menstrual Health Supplements Market, by Product, 2023-2032
8.1.1. Single Nutritional Supplements
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Combined Nutritional Supplements
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global PMS And Menstrual Health Supplements Market, By Consumer Group
9.1. PMS And Menstrual Health Supplements Market, by Consumer Group, 2023-2032
9.1.1. Premenstrual Syndrome (PMS)
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Perimenopause
9.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global PMS And Menstrual Health Supplements Market, By Formulation
10.1. PMS And Menstrual Health Supplements Market, by Formulation, 2023-2032
10.1.1. Capsules/Tablets
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Powder
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Softgels
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global PMS And Menstrual Health Supplements Market, By Sales Channel
11.1. PMS And Menstrual Health Supplements Market, by Sales Channel, 2023-2032
11.1.1. Online Sales Channel
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Direct Sales Channel
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Pharmacies/Drug Stores
11.1.3.1. Market Revenue and Forecast (2019-2032)
11.1.4. Other Offline Channels
11.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global PMS And Menstrual Health Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.1.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.1.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.1.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.1.6.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.2.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.2.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.2.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.2.6.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.2.7.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.2.8.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.3.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.3.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.3.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.3.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.3.6.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.3.6.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.3.7.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.3.7.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.3.8.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.3.8.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.4.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.4.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.4.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.4.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.4.6.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.4.6.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.4.7.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.4.7.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.4.8.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.4.8.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.5.5.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.5.5.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Consumer Group (2019-2032)
12.5.6.3. Market Revenue and Forecast, by Formulation (2019-2032)
12.5.6.4. Market Revenue and Forecast, by Sales Channel (2019-2032)
Chapter 13. Company Profiles
13.1. Herbalife International of America, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Pharmavite LLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nature’s Bounty
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Amway
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GNC Holdings, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. USANA Health Sciences, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GlaxoSmithKline Plc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. MetP Pharma AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. RBK Nutraceuticals Pty Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Archer Daniels Midland
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers